Sino Medical Sciences Technology Board Elects Chairman

The board of Sino Medical Sciences Technology (SHA:688108) elected Sun Jianhua as chairman of the board. The chair has a term of three years, according to a Friday filing with the bourse.

MT NewswiresJun 6 23:22 ET

China Approves Sino Medical's Intracranial Stent System

China approved Sino Medical Sciences Technology (SHA:688108) subsidiary Sino Medical Science and Technology's product registration for a self-expanding intracranial drug-eluting stent system. The devi

MT NewswiresMay 29 04:32 ET

Sano Medical (688108.SH): Subsidiary's self-inflating intracranial drug-coated stent system application for domestic medical device registration was accepted

On May 28, Ge Longhui Medical (688108.SH) announced that the self-inflating intracranial drug coating stent system independently developed by the company's subsidiary Sano Shenchang Medical Technology Co., Ltd. (“Sano Shenchang” or “subsidiary”) submitted a medical device registration application to the State Drug Administration in May 2024. The State Drug Administration recently issued a “Notice of Acceptance” to the company. Expected use: The self-inflating intracranial drug coating stent system is used for intracranial atherosclerotic stenosis. It supports and opens the stenosis and obstructed lumen, improves intracranial artery lumen diameter, and improves brain tissue ischemia

Gelonghui FinanceMay 28 05:57 ET

Sano Healthcare (688108.SH): Currently, the business mainly covers key areas of interventional treatment such as cardiovascular, cerebrovascular, and structural heart diseases

Gelonghui, May 10 | Sano Healthcare (688108.SH) said on the investor interactive platform that the company is an international company rooted in China, targeting the global market, and focusing on R&D, production and sales of high-end interventional medical devices. Currently, the company's business mainly covers key areas of interventional treatment such as cardiovascular, cerebrovascular, and structural heart diseases.

Gelonghui FinanceMay 10 03:35 ET

Sino Medical Sciences Technology Inc. (SHSE:688108) Surges 13%; Retail Investors Who Own 41% Shares Profited Along With Insiders

Key Insights Significant control over Sino Medical Sciences Technology by retail investors implies that the general public has more power to influence management and governance-related decisions The

Simply Wall StApr 27 20:30 ET

Sano Healthcare (688108.SH) reported 2023 annual results with a net loss of 39.63 million yuan

Sano Healthcare (688108.SH) released its 2023 annual report. The company achieved operating income of 3 during the reporting period...

Zhitong FinanceApr 26 07:59 ET